RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Md Nurunnabi to Stomach Neoplasms

Back to Details
This is a "connection" page, showing publications Md Nurunnabi has written about Stomach Neoplasms.
Md Nurunnabi
Connection Strength
1.583
Stomach Neoplasms
  1. Kumar R, Afrin H, Bhatt HN, Beaven E, Gangavarap A, Esquivel SV, Zahid MI, Nurunnabi M. Mucoadhesive Carrier-Mediated Oral Co-delivery of Bcl2 Inhibitors Improves Gastric Cancer Treatment. ACS Appl Mater Interfaces. 2024 Jan 10; 16(1):305-317.
    View in: PubMed
    Score: 0.806
  2. Afrin H, Esquivel SV, Kumar R, Zahid MI, Oporeza B, Rahman MF, Boland T, Nurunnabi M. ?-Glucan-Mediated Oral Codelivery of 5FU and Bcl2 siRNA Attenuates Stomach Cancer. ACS Appl Mater Interfaces. 2023 Jul 12; 15(27):32188-32200.
    View in: PubMed
    Score: 0.777
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support